Tang, Tzu-Chieh http://orcid.org/0000-0002-6215-8714
Tham, Eléonore
Liu, Xinyue
Yehl, Kevin
Rovner, Alexis J.
Yuk, Hyunwoo http://orcid.org/0000-0003-1710-9750
de la Fuente-Nunez, Cesar
Isaacs, Farren J.
Zhao, Xuanhe
Lu, Timothy K. http://orcid.org/0000-0002-3918-8923
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1R01HL153857-01, 1DP2OD008435)
National Science Foundation (EFMA-1935291)
United States Department of Defense | United States Army | U.S. Army Research, Development and Engineering Command | Army Research Office (W911NF-13-D-0001)
United States Department of Defense | United States Navy | Office of Naval Research (N00014-13-1-0424)
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-15-C-0091)
NIH National Centers for Systems Biology
Article History
Received: 29 February 2020
Accepted: 25 February 2021
First Online: 5 April 2021
Competing interests
: T.-C.T., E.T., X.L., H.Y., X.Z. and T.K.L. have filed a patent application based on the hydrogel encapsulation technologies with the US Patent and Trademark Office. T.K.L. is a cofounder of Senti Biosciences, Synlogic, Engine Biosciences, Tango Therapeutics, Corvium, BiomX, Eligo Biosciences, Bota.Bio, Avendesora and NE47Bio. T.K.L. also holds financial interests in nest.bio, Armata, IndieBio, MedicusTek, Quark Biosciences, Personal Genomics, Thryve, Lexent Bio, MitoLab, Vulcan, Serotiny, Avendesora and Pulmobiotics.